Navigation Links
FDA Approves New Type of Flu Vaccine

WEDNESDAY, Jan. 16 (HealthDay News) -- The U.S. Food and Drug Administration has approved a novel type of flu vaccine, the agency announced Wednesday.

Flublok, as the vaccine is called, does not use the traditional method of the influenza virus or eggs in its production. Instead, it is made using an "insect virus (baculovirus) expression system and recombinant DNA technology," the FDA said in a news release. This will allow vaccine maker Protein Sciences Corp., of Meriden, Conn., to produce Flublok in large quantities, the agency added.

The vaccine is approved for use in those aged 18 to 49.

"This approval represents a technological advance in the manufacturing of an influenza vaccine," said Dr. Karen Midthun, director of the FDA's Center for Biologics Evaluation and Research. "The new technology offers the potential for faster start-up of the vaccine manufacturing process in the event of a pandemic, because it is not dependent on an egg supply or on availability of the influenza virus."

While the technology is new to flu vaccine production, it has been employed in the making of vaccines that prevent other infectious diseases, the agency noted.

As it does with all influenza vaccines, the FDA will assess Flublok before each flu season. In research conducted at various sites in the United States, Flublok was about 45 percent effective against all circulating influenza strains, not just the strains that matched those in the vaccine. The most commonly reported adverse reactions included pain at the site of injection, headache, fatigue and muscle aches -- events also typical for conventional flu vaccines, the agency said.

The new flu vaccine could not have come at a better time, with the flu season well under way and sporadic shortages of both the traditional flu vaccine and the flu treatment Tamiflu.

"We have received reports that some consumers have found spot shortages of the vaccine," FDA Commissioner Dr. Margaret Hamburg said Monday on her blog on the agency's website.

So far, more than 128 million doses of flu vaccine have been distributed, Hamburg said, but not all the doses have been administered to people yet.

She said that people who already have the flu may also be experiencing local shortages of Tamiflu.

"We do anticipate intermittent, temporary shortages of the oral suspension form of Tamiflu -- the liquid version often prescribed for children -- for the remainder of the flu season. However, FDA is working with the manufacturer to increase supply," she said.

Flu season typically peaks in January or February but can extend as late as May. This flu season is turning out to be more severe than last year's.

Officials at the U.S. Centers for Disease Control and Prevention said on Friday that 47 states were reporting widespread influenza activity, although flu case numbers were beginning to subside in some regions, especially in the Southeast, where the flu showed up first.

It's still not too late to get a flu shot to help protect yourself, Hamburg stressed. She noted that it takes about two weeks after vaccination for your body to develop an immune response to provide protection against the flu.

People who want to get vaccinated can visit, click on the "Flu Vaccine Finder," enter their zip code and find a list of clinics, supermarkets, pharmacies and other flu vaccination locations in their neighborhoods.

But before you go to one of the locations, call ahead to confirm that they have the flu vaccine, Hamburg advised.

According to recommendations from the CDC, all adults and children who are at least 6 months old should receive a flu vaccination each year. The best time to get vaccinated is in the fall.

More information

The U.S. Centers for Disease Control and Prevention has more about the flu and flu vaccine.

-- Robert Preidt

SOURCE: Jan. 16, 2013, news release, U.S. Food and Drug Administration; Jan. 15, 2013, blog, Dr. Margaret Hamburg, Commissioner, U.S. Food and Drug Administration

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. FDA Approves New Once-a-Day HIV Pill
2. FDA Approves Flu Vaccine for Coming Season
3. FDA Approves 2nd New Weight-Loss Drug
4. FDA Approves 1st Pill to Help Prevent HIV Infection
5. FDA Approves First New Weight-Loss Drug in More Than a Decade
6. FDA Approves SonixGPS Needle Guidance Technology for Vascular Access Procedures
7. FDA Approves Combo Shot for Meningitis, Hib in Kids
8. FDA Approves Generic Versions of Plavix
9. Childhood Vaccine Schedule Is Safe, Report Says
10. Spot Shortages of Flu Vaccine, Tamiflu Reported, FDA Head Says
11. Major step toward an Alzheimers vaccine
Post Your Comments:
Related Image:
FDA Approves New Type of Flu Vaccine  
(Date:11/30/2015)... York (PRWEB) , ... November 30, 2015 , ... In ... of his role as a top ophthalmologist on Long Island’s east end. During the ... teaching, innovations in surgery and treatment of glaucoma and cataracts, and how a visit ...
(Date:11/30/2015)... ... November 30, 2015 , ... Since its ... specializing in independent living, assisted living and all other retirement options. Support for ... awareness and research remains a top priority. , So it’s no surprise ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... of the leading plastic surgery practices in Florida, is proud to announce that ... for surgical innovations giant Ethicon Inc., a Johnson & Johnson Company. , Ethicon ...
(Date:11/30/2015)... New York, New York (PRWEB) , ... November 30, 2015 , ... ... at the Greater New York Dental Meeting. Their Ecosystem empowers dentists to make complex ... Dentists who visit the booth will receive a free fee survey with 10 procedures ...
(Date:11/30/2015)... ... 30, 2015 , ... Vasont Systems, a top component content ... extension unites with Syncro Soft’s latest software update, oXygen XML editor Version 17.1. ... the latest release of oXygen® XML editor and the Vasont® CCMS. , ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... 2015 2014RestatedChange%Turnover 545,575 , 518,852 , 5.2 Cord Blood ... , 9.8 Hospital Management Service Income , ... Medical Insurance Administration Service Income , 2,780 , ... , 89,645 , 94,580 , ... 2,917 , (3.3) Gross Profit 395,857 , ...
(Date:11/30/2015)...  PTS Diagnostics, the U.S.-based manufacturer of point-of-care biometric ... ® systems, and PTS Detect™ cotinine systems, has ... will propel the company into the mHealth market. ... . The technology is a system that interfaces ... and tablets, and uses test strip technology already developed ...
(Date:11/30/2015)... Nov. 30, 2015 Cumberland Pharmaceuticals (CPIX), today announced that ... at on December 3, 2015. TIME: 3:15p.m. ... 3:15p.m. ET LINK: --> ... --> --> ... investors are invited to ask the company questions in real-time ...
Breaking Medicine Technology: